StockNews.com Begins Coverage on China Pharma (NYSE:CPHI)

Equities research analysts at StockNews.com started coverage on shares of China Pharma (NYSE:CPHI) in a research note issued on Sunday. The brokerage set a “hold” rating on the stock.

China Pharma Stock Down 5.4 %

CPHI opened at $0.27 on Friday. China Pharma has a 12-month low of $0.13 and a 12-month high of $0.41. The company has a quick ratio of 0.26, a current ratio of 0.79 and a debt-to-equity ratio of 0.22. The firm’s fifty day moving average price is $0.23 and its 200 day moving average price is $0.22.

About China Pharma

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.